Immune Therapeutics, Inc. is a biotechnology company
applying its patented immunotherapy to combat chronic, life-threatening
diseases that affect persons around the world. Building on the power of the
body’s natural immune system, the company’s pipeline of products and
immunotherapy technologies are designed to enhance treatment of cancer,
infections such as HIV/AIDS, chronic inflammatory diseases, and a variety of
autoimmune diseases.
Immune Therapeutics’ most advanced clinical programs involve
immunotherapy with met-enkephalin (MENK) (sometimes referred to as opioid
growth factor) and its low dose naltrexone product (LDN), internationally known
as Lodonal™, both of which have been shown to stimulate immune systems even in
patients with advanced cancer.
Additionally, Immune Therapeutics is pursuing additional
investigations for MENK and LDN as viable treatments for autoimmune conditions
such as rheumatoid arthritis and multiple sclerosis; as an adjunct in cancer
patients undergoing chemotherapy, radiation treatments or surgery; and as a
complement to antibiotics in the treatment of a variety of infectious diseases,
including patients with HIV/AIDS, in combination with retroviral drug therapy.
Immune Therapeutics and partners AHAR Pharma and GB Pharma
Holdings recently completed a bridging trial to determine the safety and
efficacy of LDN in patients with HIV, and have submitted data in connection
with the filing of its New Drug Application for LDN with The National Agency
for Food and Drug Administration and Control, (NAFDAC) of Nigeria.
Learn more by visiting www.immunetherapeutics.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
No comments:
Post a Comment